Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 3,062: | Line 3,062: | ||
| | | | ||
|- | |- | ||
|Neurofibromatosis Type 1||Disease|| | |Neurofibromatosis Type 1||Disease||Ngoni Faya | ||
| | | | ||
| | | | ||
| Line 3,070: | Line 3,069: | ||
| | | | ||
| | | | ||
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content. | |||
|- | |- | ||
|Neurofibromatosis Type 2||Disease|| | |Neurofibromatosis Type 2||Disease|| | ||
| Line 3,132: | Line 3,132: | ||
|LS | |LS | ||
| | | | ||
| | |NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content. | ||
|- | |- | ||
|Familial Adenomatous Polyposis 1||Disease|| | |Familial Adenomatous Polyposis 1||Disease|| | ||
| Line 3,177: | Line 3,177: | ||
|LS | |LS | ||
| | | | ||
| | |NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content. | ||
|- | |- | ||
|Familial Paraganglioma Syndromes||Disease|| | |Familial Paraganglioma Syndromes||Disease|| | ||
| Line 3,964: | Line 3,964: | ||
| | | | ||
|- | |- | ||
|Neurofibromatosis Type 1||Disease|| | |Neurofibromatosis Type 1||Disease||Ngoni Faya | ||
| | | | ||
| | | | ||
| Line 3,972: | Line 3,971: | ||
| | | | ||
| | | | ||
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content. | |||
|- | |- | ||
|Polygenic Component of Breast Cancer Susceptibility | |Polygenic Component of Breast Cancer Susceptibility | ||
| Line 4,003: | Line 4,003: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book | ||
|- | |- | ||
|DICER1-Related Tumour Predisposition Syndrome (DICER1) | |DICER1-Related Tumour Predisposition Syndrome (DICER1) | ||
| Line 4,009: | Line 4,009: | ||
|Jennie Thurston | |Jennie Thurston | ||
|7/2/2023 | |7/2/2023 | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|Named based on GTS5 book | |||
|- | |||
|Neurofibromatosis Type 1 (NF1) | |||
|Disease | |||
| | |||
| | | | ||
| | | | ||
| Line 4,015: | Line 4,025: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book | |||
|- | |- | ||
|}<br /> | |}<br /> | ||